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RNA Polymerase II Holoenzyme
Contains SWI/SNF Regulators
Involved in Chromatin Remodeling
Christopher J. Wilson,* David M. Chao,* targeted to promoters, although some gene-specific ac-
tivators may interact directly with these proteins (Yoshi-Anthony N. Imbalzano,² Gavin R. Schnitzler,²
naga et al., 1992).Robert E. Kingston,² and Richard A. Young*
Genetic and biochemical studies in yeast indicate that*Whitehead Institute for Biomedical Research
the form of the transcription initiation apparatus gener-Nine Cambridge Center
ally responsible for mRNA synthesis in vivo is an RNACambridge, Massachusetts 02142
polymerase II holoenzyme (Barberis et al., 1995; Hengar-and Department of Biology
tner et al., 1995; Kim et al., 1994; Koleske and Young,Massachusetts Institute of Technology
1994; Thompson and Young, 1995; reviewed by Carey,Cambridge, Massachusetts 02139
1995; Emili and Ingles, 1995; Koleske and Young, 1995).²Department of Molecular Biology
This megadalton-sized complex contains RNA polymer-Massachusetts General Hospital
ase II, general transcription factors, and additional com-Boston, Massachusetts 02114
ponents called suppressor of RNA polymerase B (SRB)and Department of Genetics
regulatory proteins. The SRB proteins are a hallmark ofHarvard Medical School
the holoenzyme. The genes encoding the nine knownBoston, Massachusetts 02115
SRB proteins were identified through a selection for
factors involved in transcription initiation by RNA poly-
merase II in vivo, and all are required for normal yeast
Summary cell growth. Essentially all of the SRB protein in cells is
tightly associated with the holoenzyme, while approxi-
The RNA polymerase II holoenzyme contains RNA mately 80% of RNA polymerase II and general transcrip-
polymerase II, a subset of general transcription factors tion factors are found independent of this complex
and SRB regulatory proteins. We report here that SWI (Koleske and Young, 1995). Experiments with tempera-
and SNF gene products, previously identified as global ture-sensitive SRB mutants indicate that the RNA poly-
gene regulators whose functions include remodeling merase II holoenzyme is the form of the transcription
chromatin, are also integral components of the yeast initiation apparatus employed at the majority of class II
RNA polymerase II holoenzyme. The SWI/SNF proteins promoters in vivo (Thompson and Young, 1995). Other
are components of the SRB complex, also known as experiments have shown that recruiting a component
the mediator, which is tightly associated with the RNA of the SRB complex topromoters, presumably inassoci-
polymerase II C-terminal repeat domain. The SWI/SNF ation with the holoenzyme, suffices to obtain activated
levels of transcription in vivo (Barberis et al., 1995).components provide theholoenzyme with thecapacity
The yeast SWI genes were first identified as positiveto disrupt nucleosomal DNA and thus facilitate stable
regulators of HO transcription (Stern et al., 1984), andbinding of various components of the transcription
SWI1, SWI2, and SWI3 were later shown to be requiredinitiation complex at promoters.
for the activation of a broad spectrum of inducible genes
in vivo (Peterson and Herskowitz, 1992; Yoshinaga et
Introduction al., 1992). Similarly, the SNF genes were originally identi-
fied as positive regulators of SUC2 (Neigeborn and Carl-
Regulation of class II genes involves a complex interplay son, 1984), and SNF2, SNF5, and SNF6 were subse-
among gene-specific activators and cofactors, the gen- quently found to be essential for activation of a diverse
eral transcription apparatus, and chromatin. Gene-spe- set of inducible genes (Laurent and Carlson, 1992;
cific activators bind to promoters and stimulate tran- Laurent et al., 1991; Peterson and Herskowitz, 1992).
scription, at least in part, by binding and recruiting the Further study revealed that SWI2 and SNF2 are the same
general transcriptionapparatus (Chen et al., 1994; Heng- gene. Genetic evidence indicated that the SWI and SNF
artner et al., 1995; Ingles et al., 1991; Lin et al., 1991; genes are involved in similar processes in gene activa-
Xiao et al., 1994; reviewed by Tjian and Maniatis, 1994; tion (Carlson and Winston, 1992). Indeed, the discovery
Sheldon and Reinberg, 1995; Emili and Ingles, 1995; that SWI1, SWI2/SNF2, SWI3, SNF5, SNF6, and SNF11
Carey, 1995). Chromatin structure can affect the tran- proteins copurify in a large complex confirmed that the
scriptional activity of genes by blocking access of the SWI/SNF gene products function together (Cairns et al.,
transcription apparatus to promoters (Knezetic and 1994; CoÃ teÂ et al., 1994; Peterson et al., 1994; Treich et
Luse, 1986; Bresnick and Felsenfeld, 1993; Felsenfeld, al., 1995). Genetic and biochemical evidence implicated
1992; Lorch et al., 1988; Workman and Roeder, 1987). the SWI/SNF proteins in chromatin remodeling via
The SWI and SNF proteins are global regulators that nucleosome disruption (Cairns et al., 1994; CoÃ te et al.,
function by antagonizing repression mediated by 1994; Hirschhorn et al., 1992; Peterson et al., 1994).
nucleosomes, altering chromatin structure to facilitate Several lines of evidence led us to investigate whether
binding of the transcription apparatus (CoÃ teÂ et al., 1994; SWI and SNF proteins are components of the RNA poly-
Hirschhorn et al., 1992; Imbalzano et al., 1994; Kwon merase II holoenzyme, and furthermore, whether SWI/
et al., 1994; reviewed by Carlson and Laurent, 1994; SNF proteins are components of the SRB-containing
Peterson and Tamkun, 1995; Winston and Carlson, protein complex that is tightly associated with the
C-terminal repeat domain (CTD) in the holoenzyme.1992). It is not yet clear how the SWI/SNF proteins are
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First, genetic evidence suggests a functional relation-
ship between the SWI and SNF gene products and the
CTD. Strains containing mutations in SWI genes exhibit
a large number of defects similar to those due to a
truncation of the RNA polymerase II CTD (Nonet et al.,
1987; Peterson and Herskowitz, 1992; Peterson et al.,
1991). In addition, the CTD and the SWI/SNF gene prod-
ucts show similar genetic interactions with mutations in
SIN1 and SIN2, genes that encode chromatin-associ-
ated proteins (Peterson and Herskowitz, 1992; Peterson
et al., 1991). Second, the SRB gene products have func-
tional and physical interactions with the RNA polymer-
ase II CTD (Koleske and Young, 1995), which has been
implicated in the response to activators in yeast and
mammalian cells (Allison and Ingles, 1989; Gerber et al.,
1995; Scafe et al., 1990). Third, the holoenzyme appears
to be responsible for initiating transcription of most, if
not all, class II genes in yeast, and the SWI and SNF
Figure 1. Immunoprecipitation of RNA Polymerase II Holoenzymegene products are required for transcriptional induction from Crude Extracts Using Anti-SRB5 and Anti-SWI3 Antibodies
of a large number of genes in vivo (Thompson and
Immunoprecipitations were from a crude DEAE fraction prepared
Young, 1995; Peterson et al., 1991). Finally, there are as described by Hengartner et al. (1995). Immunoprecipitations were
perhaps a dozen polypeptides in purified yeast RNA carried out with affinity-purified antibodies against SWI3, SRB5, or
polymerase holoenzyme that have yet to be identified. TGFb. Ovalbumin and HA-tagged GST were added to each reaction
prior to precipitation to serve as controls for specific immunoprecipi-We report here that the yeast RNA polymerase II holo-
tation; 1/50 of the onput and flowthrough, and 1/5 of the final washenzyme contains SWI2/SNF2, SWI3, SNF5, and SNF11.
and eluate were subjected to SDS±PAGE and analyzed by WesternThe SWI/SNF proteins are components of the SRB
blotting using specific antibodies.
complex, also known as the mediator, which is tightly
associated with the RNA polymerase II CTD. Both the
SRB and SWI/SNF proteins are tightly associated withholoenzyme and the SRB/SWI/SNF complex have ATP-
one another.dependent nucleosome disruption activities previously
ascribed to the SWI/SNF complex. In addition, the holo-
Purified Holoenzyme Containsenzyme facilitates the binding of TATA box±binding pro-
SWI/SNF Proteins
tein (TBP) to nucleosomal DNA in an ATP-enhanced
The immunoprecipitation results led us to investigate
manner.
whether SWI and SNF proteins are components of puri-
fied yeast RNA polymerase II holoenzyme. Antibodies
against selected SWI and SNF proteins were used toResults
determine whether these proteins coelute with the RNA
polymerase II holoenzyme in the final purification stepAnti-SRB and Anti-SWI Antibodies
of the holoenzyme. The data in Figure 2A demonstrateCoprecipitate Holoenzyme
that SNF2/SWI2, SNF5, SWI3, and SNF11 proteins coe-
SRB regulatory proteins are found tightly and exclu-
lute with other known components of the holoenzyme
sively associated with other components of the RNA
and with transcription activity.
polymerase II holoenzyme in cell extracts. If SWI and The holoenzyme contains stoichiometric amounts of
SNF proteins are subunits of the RNA polymerase II
RNA polymerase II, SRB proteins, and general transcrip-
holoenzyme, then antibodies against SRB5 should tion factors. To ascertain whether the SWI/SNF proteins
precipitate both the holoenzyme and SWI/SNF pro- are stoichiometric components of the holoenzyme, the
teins from crude extracts. The results in Figure 1 show amounts of SNF2 and SNF5 were estimated by Western
that this is indeed the case. SWI2/SNF2, SWI3, and blot analysis with various amounts of recombinant pro-
SNF5 proteins coprecipitate with holoenzyme obtained teins as standards (Figure 2B). These data indicate that
through SRB5 immunoprecipitation. The fraction of SWI the purified RNA polymerase II holoenzyme contains
and SNF proteins immunoprecipitated from the crude approximately equimolar amounts of SNF2, SNF5, and
extract appears to be the same as that of the SRB pro- SRB5, the latter being a standard against which other
teins. Control proteins introduced into the crude lysate holoenzyme components have previously been com-
did not coprecipitate, indicating that the immunoprecipi- pared (Koleske and Young, 1994). Since yeast cells con-
tate was specific for theholoenzyme. When the immuno- tain between 2000 and 4000 molecules of RNA polymer-
precipitation experiment was carried out with antibody ase II holoenzyme, it appears that there are at least this
against SWI3, essentially identical results were obtained number of SWI2/SNF2 and SNF5 molecules per cell.
(Figure 1). The SWI/SNF and SRB proteins were immu-
noprecipitated from the crude extract with similar effi- SWI/SNF Proteins Are Components of
ciency whether the immunoprecipitating antibody used CTD-Binding SRB Complexes
was directed against SRB5 or SWI3. A control experi- Genetic evidence indicates that the SRB regulatory pro-
ment with antibody against TGFb failed to precipitate teins and the RNA polymerase II CTD have related func-
tions in transcription initiation and that these involveSWI/SNF or SRB proteins. These results indicate that
RNA Polymerase II Holoenzyme Contains SWI/SNF
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Figure 3. SWI/SNF Proteins Are Present in Mediator Purified Using
8WG16 Monoclonal Antibodies
Mediator was Western blotted along with holoenzyme and core
polymerase and probed for the presence of SWI/SNF proteins. The
mediator preparation was previously assayed (Hengartner et. al.,
1995) and shown to have all transcriptional activities previously
described (Kim et. al., 1994).
son et al., 1993). An SRB complex was purified exten-
sively by using a recombinant glutathione S-transferase
(GST)±CTD column, followed by chromatography with
Mono S and Mono Q columns (Figure 4A). The SRB,
SWI, and SNF proteins bind to a GST±CTD column, but
not to a control GST column, indicating that they bind
specifically to the CTD (Figure 4B). Sliver staining and
Western blotting confirm that both a multiprotein com-
plex containing SRB proteins and each of the three as-
Figure 2. SWI/SNF Proteins Are Components of Purified RNA Poly- sayed SWI/SNF proteins coelute from the Mono Q col-
merase II Holoenzyme
(A) RNA polymerase II holoenzyme eluted from a Mono S column,
the last chromatographic step in the purification procedure (Koleske
and Young, 1994), was analyzed for transcriptional activity and for
the presence of SRB and SWI/SNF proteins by Western blotting.
(B) Quantitative Western blots were used to determine the relative
amounts of SRB5 and SWI/SNF proteins in the holoenzyme. Known
amounts of recombinant GST±SNF2/SWI21256±1703, GST±SNF51±193,
and SRB5 were subject to SDS±PAGE and Western blot analysis
along with 2.5 ml and 0.5 ml of purified holoenzyme. There are similar
levels of SNF2/SWI2, SNF5, and SRB5 in the purified holoenzyme
Previous studies have shown that RPB1 and other SRB proteins
are equimolar in purified holoenzyme (Koleske and Young, 1994).
the response to transcriptional regulators (Allison and
Ingles, 1989; Gerber et al., 1995; Scafe et al., 1990;
Koleske and Young, 1995). Since the SWI and SNF pro-
teins are also involved in activation of a wide variety of
genes and since mutations in SWI and SNF genes can
produce phenotypes similar to those observed with mu-
tations in SRB genes, we investigated whether SWI and
SNF proteins are associated with the SRB complex.
The SRB protein complex can be released from the
holoenzyme when the latter is treated with monoclonal
antibodies against the CTD, and this preparation has
been called mediator (Kim et al., 1994). We previously
prepared a mediator complex according to the proce-
dure of Kim et al. (1994), confirmed that it has the coacti- Figure 4. An SRB/SWI/SNF Complex Purified Using CTD Affinity
vator activity described by these investigators, and Chromatography
showed that the mediator contains all of the SRB pro- (A) Schematic diagram of the purification.
(B) SRB, SWI, and SNF proteins bind specifically to a GST±CTDteins (Hengartner et al., 1995). When this mediator prep-
column. Western blot analysis of proteins eluted from a GST columnaration was assayed for the presence of SNF2/SWI2,
and from a GST±CTD column. TFIIE was a negative control forSNF5, and SWI3 proteins by Western blot, all three SWI/
specific retention, as it does not bind GST or GST±CTD.
SNF proteins were found (Figure 3). (C) Silver stain of fractions across the final Mono Q column.
The SRB complex can also be isolated from crude (D) Western blot analysis of SRB and SWI/SNF proteins across the
final Mono Q column.extracts using a recombinant CTD column (Thomp-
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Figure 5. Components of the RNA Poly-
merase Holoenzyme and the SRB/SWI/SNF
Complex
(A) Silver stain of purified RNA polymerase II.
Bands that correspond in size to RNA poly-
merase core subunits, SRB, SWI, and SNF
proteins, and general transcription factor IIB,
IIF, and IIH subunits are indicated.
(B) Silver stain of the SRB/SWI/SNF complex.
Bands that correspond in size to SRB, SWI,
and SNF proteins are indicated.
umn (Figures 4C and 4D). There are approximately 25 SWI/SNF complex showed that the nucleosome disrup-
polypeptides in this complex, and several correspond in tion activity was ATP dependent (Figures 6B and 6D), as
size to previously identified SRB, SWI, and SNF proteins was previously shown for purified SWI/SNF complexes
(Figure 5). No signals were obtained when Western blots (CoÃ teÂ et al., 1994; Imbalzano et al., 1994; Kwon et al.,
containing the SRB/SWI/SNF complex were probed with 1994). In addition, purified core RNA polymerase II
antibodies against RNA polymerase II, TBP, TFIIB, or the showed no nucleosome alteration capability (data not
TFB1 subunit of TFIIH (data not shown). These results shown). These data indicate that the SRB/SWI/SNF
indicate that the SRB complex is in fact an SRB/SWI/ complex contributes chromatin remodeling activity to
SNF complex and, furthermore, that the SWI and SNF the RNA polymerase II holoenzyme.
proteins interact with the holoenzyme, at least in part
through their association with RNA polymerase II CTD.
Purified Holoenzyme and the SRB/SWI/SNF
Complex Disrupts Plasmid ChromatinNucleosome Disruption Activity in Holoenzyme
To characterize further the nucleosome disruption capa-and SRB/SWI/SNF Complex
bilities of the holoenzyme and the SRB/SWI/SNF com-Previous evidence that SWI1, SWI2, SWI3, SNF5, SNF6,
plex, we employed a supercoiling reduction assay (Fig-and SNF11 gene products can be isolated as a large
ure 7). In this assay, chromatin is assembled onto amultisubunit complex capable of altering nucleosome
relaxed closed-circular plasmid that is subsequently pu-structure led us to investigate whether the purified RNA
rified by glycerol gradient centrifugation. Each assem-polymerase II holoenzyme and the SRB/SWI/SNF com-
bled nucleosome introduces approximately one nega-plex were able to alter nucleosome structure. Mono-
tive supercoil to the plasmid, which can be resolved bynucleosome particles were reconstituted from purified
agarose gel electrophoresis after the removal of his-histone octamers and a DNA fragment containing two
tones. When no protein is added to the nucleosome-copies of an artificial phasing sequence (Shrader and
assembled plasmid, it is highly supercoiled. FractionsCrothers, 1989). Digestion of the mononucleosomes
from the last column of the holoenzyme purification (seewith DNase I showed a 10 bp cleavage ladder typical of
Figure 2A) were tested for their ability to disrupt nucleo-a rotationallyphased nucleosome (Figure 6).Fractions in
some structure and thereby reduce supercoiling in thethe last chromatographic step in the purification of the
presence of added topoisomerase I. As can be seen inholoenzyme were mixed with mononucleosomes and
Figure 7A, this activity coelutes with holoenzyme tran-assayed for the ability to alter nucleosome structure,
scription activity, with the SRB and SWI/SNF proteinswhich can be visualized by changes in the accessibility
(see Figure 2A), and with nucleosome-core disruptionof the nucleosome to DNase I cleavage. Figure 6A dem-
activity (see Figure 6A).The supercoiling reduction activ-onstrates that a nucleosome disruption activity coeluted
ity was dependent on ATP (Figure 7A, compare fractionwith the RNA polymerase holoenzyme. The ability of the
61 plus and minus ATP), as has been shown for theSRB/SWI/SNF complex to alter nucleosome structure
human SWI/SNF complex (Kwon et al., 1994). Repeatingwas assayed in a similar experimentusing fractions from
the experiment using fractions from the last column ofthe last step in the SRB/SWI/SNF purification (Figure
the SRB/SWI/SNF complex shows that this complex6C). The results show that nucleosome disruption activ-
also has an ATP-dependent supercoiling reduction ac-ity coeluted with the SRB/SWI/SNF complex. Further
analysis of the RNA polymerase II holoenzyme and SRB/ tivity (Figure 7B).
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Holoenzyme Facilitates the Binding of TBP
to Nucleosomes
Previous work has shown that both yeast and human
SWI/SNF complexes can facilitate transcription factor
binding tonucleosomal DNAcontaining the relevant fac-
tor-binding site (CoÃ teÂ et al, 1994; Imbalzano et al, 1994;
Kwon et al, 1994). We tested whether the holoenzyme
could increase the binding of TBP to a mononucleosome
containing a TBP-binding site. With holoenzyme and
ATP present, TBP and TFIIA bound to the mononucleo-
some at TBP concentrations of 4 3 1026 M (Figure 8A,
lane 7), while no TBP/TFIIA binding was observed in the
absence of holoenzyme (Figure 8A, lane 6).
This holoenzyme-facilitated TBP binding might be
caused by the stabilizing effects of the additional pro-
tein±protein and protein±DNA interactions that occur in
the presence of RNA polymerase and general transcrip-
tion factors, by the ATP dependent nucleosome disrup-
tion effects of SWI/SNF, or by a combination of both
effects. To address this issue, we tested whether facili-
tated TBP binding was ATP dependent and observed
partial protection of the TATA region on the mono-
nucleosome when ATP is withheld or when ATPgS is
used instead of ATP (Figure 8B, lanes 4 and 6). However,
addition of ATP enhanced the TBP binding as indicated
by the increased protection from DNase I cleavage over
the TATA box, the extension of the footprint in the 59
direction, and the appearance of a hypersensitive band
in the 39 direction (Figure 8B, lane 5). Thus, it appears
that the holoenzyme can partially stabilize binding of
TBP and TFIIA to a mononucleosome in the absence of
ATP. However, the full effect of holoenzyme-facilitated
TBP binding requires ATP, presumably because it in-
volves the ATP-dependent nucleosome disruption activ-
ity of the SWI/SNF proteins.
Discussion
The RNA polymerase II holoenzyme contains SWI and
SNF gene products, previously identified as global gene
coactivators. The SWI and SNF proteins are compo-
nents of an SRB/SWI/SNF complex, also known as the
mediator, which is tightly associated with the RNA poly-
merase II CTD. Both the holoenzyme and the SRB/SWI/
SNF complex have nucleosome disruption activities pre-
viously ascribed to the SWI/SNF complex. In addition,
the holoenzyme facilitates the binding of TBP to nucleo-
somal DNA in an ATP-enhanced manner.
Diverse Transcriptional Activators Require
SWI/SNF Function In Vivo
Mutations in SWI1, SWI2/SNF2, SWI3, SNF5, and SNF6
cause a substantial reduction in the ability to activate
transcription of a wide variety of well-studied genesFigure 6. An ATP-Dependent Nucleosomal Disruption Activity Coe-
in yeast cells, including HO (Stern et al., 1984), SUC2lutes with the Holoenzyme and the SRB/SWI/SNF Complex
(Neigeborn and Carlson, 1984), Ty (Happel et al., 1991),(A) Fractions from the last column of holoenzyme purification (Figure
2A) were assayed for nucleosomal disruption. The peak of nucleoso-
mal disruption activity is in fractions 59±63, coincident with the peak
of transcriptional activity.
(B) Purified RNA polymerase II holoenzyme (fraction 60) was titrated peak of nucleosomal disruption activity is in fractions 23 and 24,
for activity with and without 4 mM ATP, as indicated. which is also where the bulk of SRB and SWI/SNF proteins elute.
(C) Fractions from the final column of the SRB/SWI/SNF complex (D) The SRB/SWI/SNF complex (fraction 24) was titrated for activity
purification (Figure 4) were assayed for nucleosomal disruption. The with and without 4 mM ATP, as indicated.
Cell
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Figure 7. The Holoenzyme and the SRB/SWI/
SNF Complex Reduce the Superhelical Den-
sity of Chromatin-Assembled Plasmids in an
ATP-Dependent Manner
Fractions from the last column of holoenzyme
purification (A) and from the last column of
SRB/SWI/SNF complex purification (B) were
assayed in the presence of 4 mM ATP. Peak
fractions of purified holoenzyme and SRB/
SWI/SNF complex were assayed with and
without 4 mM ATP present as described in
Experimental Procedures. The symbols o, *,
and x indicate nicked circular plasmid DNA,
linear DNA, and highly supercoiled circular
DNA, respectively.
INO1 (Peterson et al., 1991), and ADH1 and ADH2 (Pe- (Koleske and Young, 1994). Ptashne and colleagues
have shown that recruiting a component of the SRBterson and Herskowitz, 1992; Taguchi and Young, 1987).
complex to promoters, presumably in association withFor example, ADH1 and SUC2 gene expression is re-
the holoenzyme, suffices to obtain activated levels ofduced by about an order of magnitude in strains in which
transcription in vivo (Barberis et al., 1995; M. Ptashne,SWI1, SWI2, or SWI3 has been deleted (Peterson and
personal communication). Thus, evidence that LexA fu-Herskowitz, 1992). Experiments with reporter constructs
sions with SWI2/SNF2, SNF5, SNF6, and SNF11 proteinshave revealed that the SWI and SNF gene products
are sufficient to activate transcription of a target geneare required for normal responses to a variety of gene-
in vivo (Laurent et al., 1990, 1991; Treich et al., 1995)specific activators in yeast such as GAL4, Drosophila
might nowbe interpreted in terms of holoenzyme recruit-fushi tarazu, mammalian glucocorticoid and estrogen
ment to the target promoter.receptors, and LexA±GAL4 and LexA±Bicoid fusion pro-
We propose that recruitment of the holoenzyme to ateins (Peterson and Herskowitz, 1992; Laurent and Carl-
specific promoter in vivo provides a means to facilitateson, 1992; Yoshinaga et al., 1992).
TBP binding, regardless of the nucleosome structure atWe have proposed that the RNA polymerase II holoen-
that promoter. The holoenzyme can enhance binding ofzyme is recruited to promoters by activators in vivo
TBP and TFIIA to a mononucleosome in vitro in the
absence of ATP (Figure 8), a result compatible with evi-
dence that the polymerase and general transcription
factor components of the holoenzyme provide addi-
tional protein±protein and protein±DNA interactions that
should stabilize TBP binding (Buratowski, 1994). Holo-
enzyme-facilitated TBP binding to a mononucleosome
is greater in the presence of ATP, which presumably
reflects the ATP-dependent nucleosome disruption ac-
tivity of the SWI/SNF proteins. These observations are
consistent with the idea that SWI/SNF protein function is
necessary at the subset of promoters whose chromatin
structure is particularly restrictive for TBP binding.
SWI/SNF in the Holoenzyme Accounts
for Previous Genetic Observations
The presence of SWI/SNF proteins in the RNA polymer-
ase II holoenzyme and the observation that these pro-
teins are components of a subcomplex that interacts
with the RNA polymerase II CTD explain several previous
observations. SWI/SNF proteins are necessary for tran-
scription activation of many genes in yeast cells (re-
viewed by Winston and Carlson, 1992; Carlson and
Figure 8. Holoenzyme Facilitates Binding of yTBP and yTFIIA to a
Laurent, 1994; Peterson and Tamkun, 1995); CTD trun-Nucleosome Containing a TATA Box in an ATP-Enhanced Manner
cation adversely affects the response to activators in
(A) Increasing amounts of yTBP in the presence of yTFIIA and 4 mM
yeast and mammalian cells (Allison and Ingles, 1989;ATP were tested for the ability to bind to a TATA box containing
Scafe et al., 1990; Gerber et al., 1995). Cells with RNAnucleosome with and without holoenzyme present.
polymerase II CTD truncation mutations, cells with cer-(B) Nucleosomes were incubated with and without holoenzyme, 4
mM ATP or 4 mM ATPgS, yTBP and yTFIIA, as indicated. tain SRB mutations, and cells with SWI1, SWI2, or SWI3
RNA Polymerase II Holoenzyme Contains SWI/SNF
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mutations exhibit remarkably similar phenotypes (Pe- Western blot analysis did not reveal the presence of
SRB proteins (Peterson et al., 1994; Cairns et al., 1994).terson and Herskowitz, 1992; Thompson et al., 1993;
Hengartner et al., 1995). The association of the SRB/ This suggests that the purificationprocedures employed
in these studies separated the SRB and SWI/SNF pro-SWI/SNF complex with the CTD accounts for the obser-
vation that cellular defects due to CTD mutations and teins or that SWI/SNF complexes can exist independent
of the holoenzyme.SWI mutations can be alleviated by mutations in SIN1
and SIN2, which encode an HMG1-related protein and Since SWI2/SNF2 and SNF5 are stoichiometric com-
ponents of the holoenzyme and since yeast cells containhistone H3, respectively (Kruger and Herskowitz, 1991;
Peterson et al., 1991; Peterson and Herskowitz, 1992). 2000±4000 molecules of RNA polymerase II holoen-
zyme, there are at least 2000 molecules of SWI2/SNF2
and SNF5 molecules per cell. Based on their SWI/SNFSRB/SWI/SNF Complex Is Associated
complex purification, CoÃ teÂ et al. (1994) estimated thatwith the RNA Polymerase II CTD
there are between 50 and 150 copies of the SWI/SNFThe SRB/SWI/SNF complex is tightly associated with
complex in yeast cells. One interpretation of these re-the RNA polymerase II CTD. Independent attempts to
sults is that most SWI/SNF protein resides in the RNApurify various SRB proteins by column chromatography
polymerase II holoenzyme, and the form of SWI/SNFhave always led us to purify the same multiprotein com-
complex purified by CoÃ teÂ et al. (1994) is thesmall amountplex: the RNA polymerase II holoenzyme (Koleske and
of SWI/SNF protein that is in the process of assemblyYoung, 1994; Koleske et al., 1996; Hengartner et al.,
into holoenzyme or, alternatively, it represents a sub-1995; Liao et al., 1995; reviewed by Koleske and Young,
complex that can be dissociated from the holoenzyme.1995). Only very small amounts of SRB protein can be
The ability to immunoprecipitate very similar holoen-detected that are not associated with the holoenzyme.
zyme complexes from crude yeast fractions using anti-Two different methods have been described that permit
SRB and anti-SWI antibodies suggests that most of thepartial purification of an SRB subcomplex. An SRB com-
SWI/SNF protein in these fractions is associated withplex can be isolated using a CTD affinity column
the holoenzyme. If the SRB and SWI/SNF proteins were(Thompson et al., 1993) or by releasing it from a holoen-
in separate complexes, then the relative ratios of SRBzyme preparation by using monoclonal anti-CTD anti-
and SWI/SNF proteins would differ in the anti-SRB andbodies (Kim et al., 1994). Because neither of these prep-
anti-SWI immunoprecipitates. However, the similar rela-arations is homogeneous, we further purified the SRB
tive ratios of SRB and SWI/SNF proteins found in immu-complex obtained by CTD affinity chromatography (Fig-
noprecipitates obtained with anti-SRB and anti-SWI an-ure 4). The SRB and SWI/SNF proteins coelute in the
tibodies (Figure 1) indicate that the SRB and SWI/SNFfinal step of the purification.
proteins are components of the same complex in the
We also found that the SRB complex isolated by anti-
crude extract.
CTD antibody release contains SWI and SNF proteins.
Kim et al. (1994) demonstrated that reconstitution of the
SWI/SNF Function Is Highly Conservedresponse of the holoenzyme to activators required the
in Eukaryotespresence of a subcomplex that could be isolated from
SWI/SNF proteins and their functions appear to beholoenzyme with anti-CTD antibodies, which contained
highly conserved in eukaryotes. Putative homologs ofSRB2, SRB4, SRB5, and SRB6, and was called the medi-
SNF2/SWI2 include Drosophila brahma and humanator of activation. Our own studies with the mediator,
hbrm and hBRG1, which have been cloned and impli-which was purified precisely as described by Kim et
cated in transcriptional regulation (Tamkun et al., 1992;al. (1994) and has chromatographic and transcriptional
Khavari et al., 1993; Muchardt and Yaniv, 1993). A mam-properties identical to those originally described for this
malian homolog of SNF5, called INI1, has also beensubcomplex, revealed that it contained all nine of the
cloned (Kalpana et al., 1994). A human SWI/SNF com-known SRB proteins (Hengartner et al., 1995). Thus, the
plex has been partially purified that has nucleosomemediator preparation and the SRB complex obtained by
disruption activities similar to those of the yeast SWI/CTD affinity chromatography contain very similar, if not
SNF complex (Imbalzano et al., 1994; Kwon et al., 1994).identical, complexes.
The human SWI/SNF complex contains both hBRG1 andWe have shown that the RNA polymerase II holoen-
INI1 proteins (Kalpana et al., 1994; G. R. S., unpublishedzyme, and its SRB/SWI/SNF subcomplex, contain SWI2/
data), as would be expected based on the yeast results.SNF2, SWI3, SNF5, and SNF11. Although we do not
Like the yeast SWI/SNF complex, the human SWI/SNFhave direct biochemical evidence that SWI1 and SNF6
complex facilitates the binding of activators to nucleo-are present in the holoenzyme, other genetic and bio-
somal DNA.chemical data indicate that it is highly likely that SWI1
and SNF6 are also subunits of these complexes (Cairns
et al., 1994; CoÃ teÂ et al., 1994; Laurent and Carlson, 1992; Implications for Mechanisms Involved
Laurent et al., 1991; Peterson and Herskowitz, 1992). in Transcriptional Activation
Our evidence indicates that the RNA polymerase II holo-
enzyme consists of core RNA polymerase II, all theAre There Multiple SWI/SNF Complexes?
Large multisubunit complexes containing yeast SWI and general transcription factors other than TBP and TFIIA,
and a CTD-associated SRB/SWI/SNF subcomplex. TheSNF proteins have been purified to varying extents
(Cairns et al., 1994; CoÃ teÂ et al., 1994; Peterson et al., presence of the SRB/SWI/SNF subcomplex in the RNA
polymerase II holoenzyme has implications for the1994). Characterization of two of these preparations by
Cell
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proteins were eluted with buffer A plus 600 mM KOAc. Fractionsmechanisms involved in transcription activation in vivo.
containing protein were pooled, frozen in liquid nitrogen, and storedDynamic competition between chromatin proteins and
at 2708C until use. Eluates from two BioRex columns (320 ml, 1.0an activator for a specific DNA site could be resolved
g of protein) were thawed and pooled; 320 ml of buffer A plus 2%
in favor of the activator once the SWI/SNF-containing Triton X-100 were added, and the mixture was centrifuged for 30
holoenzyme was recruited to the promoter. In this min at 12,000 rpm in a GSA rotor (Sorvall). The supernatant was
loaded onto a 15 ml CTD affinity column prepared as describedmodel, the activator and the holoenzyme bothcontribute
(Thompson et al., 1993) at a flow rate of 200 ml/hr. The column wasto stable transcription initiation complex formation; the
washed with 100 ml of buffer A plus 300 mM KOAc plus 1% Tritonactivator recruits the holoenzyme by binding to a subset
X-100, or 100 ml of buffer A plus 300 mM KOAc. Bound proteinsof its components, and the SWI/SNF components of the
were eluted with buffer A plus 300 mM KOAc plus 1 M urea at a
holoenzyme enhance the stability of the activator±DNA flow rate of 25 ml/hr. Fractions containing protein (3.7 mg) were
interaction by destabilizing nucleosomes. This model is pooled, frozen in liquid nitrogen, and stored at 2708C. The CTD
column was equilibrated with buffer A plus 300 mM KOAc plus 1%attractive because it provides a simple solution to the
Triton X-100, and the flowthrough was loaded again. The columnquestion of how SWI/SNF proteins are brought to pro-
was washed and eluted as before. Fractions containing protein (1.8moters and it accounts for the coactivating and nucleo-
mg) were pooled, frozen in liquid nitrogen, and stored at 2708C.some disruption activities observed in vivo and in vitro
The CTD eluates were pooled, diluted with 1.5 vol of buffer A plus
for the SWI and SNF proteins. 0.01% NP-40, and centrifuged for 10 min at 17,000 rpm in an SS-
34 rotor (Sorvall). The supernatant was loaded onto a Mono S HR
Experimental Procedures 5/5 (Pharmacia) at a flow rate of 0.3 ml/min. The column was washed
with 3 ml of buffer A plus 120 mM KOAc plus 0.01% NP-40. Bound
proteins were eluted with a 20 ml gradient of buffer A plus 0.01%Immunoprecipitations
NP-40 from 120 mM to 1000 mM KOAc. Fractions were frozen inAll immunoprecipitations were done as described (Hengartner et
liquid nitrogen and stored at 2708C until use. Fractions containingal., 1995). In brief, 50 ml of the DEAE 400 fraction was diluted 1:4
SRB4 and SRB5 as assayed by Western blotting were pooled andwith modified transcription buffer (MTB) (50 mM HEPES±KOH [pH
diluted with 2 vol of buffer B (20 mM Tris OAc [pH 7.6] plus 20%7.3], 100 mM potassium acetate, 25 mM MgAc, 5 mM EGTA, 1 mM
glycerol plus 1 mM DTT plus 0.01% NP-40 plus protease inhibitors).DTT, 10% glycerol, 0.01% NP-40, 1 mM PMSF, 2 mM benzamidine,
The mixture was centrifuged for 5 min in a microcentrifuge. The2 mM pepstatin A, 0.6 mM leupeptin, and 2 mg/ml chymostatin) minus
supernatantwas loadedonto a Mono Q HRR 5/5 column (Pharmacia)the postassium acetate. We added 4 mg of ovalbumin, 4 mg HA-
at a flow rate of 0.3 ml/min. The column was washed with 1 ml ofGST, and 2 mg of BSA to each reaction prior to the addition of
buffer B plus 200 mM KOAc. Bound proteins were eluted with a 40antibody and then added 0.4 mg of affinity-purified a-SRB5, 0.15
ml gradient of buffer B from 200 mM to 2000 mM KOAc. The yieldmg of affinity-purified a-SWI3, or 1.5 mg of affinity-purified a-TGFb
of SRB complex was approximately 100 mg. We analyzed 1 ml ofto the respective reactions and allowed them to incubate 2 hr at
each fraction by silver staining and 7.5±10 ml of each fraction by48C; 15 ml of goat anti-rabbit covalently linked to magnetic beads
Western blotting.(Dynal) were then added and incubated for 1 hr at 48C with constant
agitation. Beads were precipitated with a magnet and washed three
times in 200 ml of MTB buffer. The final wash contained no NP-40. Nucleosomal Disruption and Facilitated
Proteins were eluted off the magnetic beads by boiling in 20 ml of Transcription Factor Binding Assays
sample buffer. The PH MLT (Figure 6) orPH MLT(13) (Figure 8) restriction fragments
were assembled into rotationally phased mononucleosome parti-
Western Blotting cles, purified by glycerol gradient centrifugation, and assayed as
All Western blots were performed as described (Koleske and Young, described (Imbalzano et al., 1994). At the nucleosome concentra-
1994). Proteins were detected with the following antibodies: SRB2, tions and reaction conditions employed in this and previous studies,
SRB4, SRB5, SRB6 (Thompson et al., 1993), SRB8, SRB9 (Hengart- nucleosomes were determined to be stable on the basis of resis-
ner et al., 1995), SRB10, SRB11 (Liao et al., 1995), SWI2/SNF2, SNF5 tance to micrococcal nuclease, the appearance of a 10 bp repeat
(gift of B. Laurent), SWI3 (gift of C. Peterson), SNF11 (gift of I. Treich pattern upon DNase I digestion, and exhibition of reduced mobility
and M. Carlson), TFIIEa, and TFIIEb (C. J. W. and R. A. Y., unpub- upon electrophoresis in native polyacrylamide gels. We have not
lished data). Quantitative Western blots were performed as de- observed the appearance of free DNA due to nucleosome dissocia-
scribed (Koleske and Young, 1994). Recombinant standards were tion in any of our experiments.
SRB5 (Thompson and Young, 1995), GST±SNF2/SWI21256±1703, and In Figure 6, holoenzyme fractions were the same as those used
GST±SNF51±193 (gifts of B. Laurent). GST proteins were purified as in Figure 1A. In Figure 6A, 0.3 ml of each fraction was assayed in
described (Smith and Johnson, 1988). Concentrations of recombi- the presence of 4 mM ATP. For the titration of holoenzyme, 0 ml,
nant proteins were determined using a colorimetric assay (Bio-Rad) 0.015 ml, 0.05 ml, 0.15 ml, and 0.5 ml of fraction 60 was used, respec-
with bovine serum albumin as a standard. tively, with and without 4 mM ATP as indicated. SRB/SWI/SNF frac-
tions were the same as those used in Figures 3C and 3D. In Figure
Purification of Holoenzyme and Mediator 6C, 1.7 ml of each fraction was assayed in the presence of 4 mM
Holoenzyme was purified as described (Koleske and Young, 1994). ATP. For the titration in Figure 6D, 0 ml, 0.07 ml, 0.2 ml, 0.7 ml, and
Transcription assays for holoenzyme were done as described 2.0 ml of fraction 24 was used, respectively, with and without 4 mM
(Koleske and Young, 1994). Mediator was purified as described ATP as indicated.
(Hengartner et al., 1995). For Figure 8, binding of yeast TBP (yTBP) and yTFIIA to nucleo-
somes containing the PH MLT(13) restriction fragment was per-
formed as previously described (Imbalzano et al., 1994). In FigureSRB/SWI/SNF Complex Purification
Whole-cell extract was prepared from Red Star yeast as described 8A, all reactions contained 4 mM ATP. Following a 30 min incubation
at 308C in the presence or absence of holoenzyme (as indicated),(Thompson et al., 1993). We centrifuged 1.2 liters of the ammonium
sulfate pellet for 30 min at 5,000 rpm in an RC3B centrifuge (Sorvall). increasing amounts of yTBP in the presence of yTFIIA were added.
TBP concentrations were 0 (lanes 1, 3, and 10), 0.04 mM (lanes 2,The pellet was resuspended in 900 ml of buffer A (20 mM K-HEPES
[pH 7.6], 1 mM EDTA, 1 mM DTT, 20% glycerol, and protease inhibi- 4, and 9), 0.4 mM (lanes 5 and 8), and 4 mM (lanes 6, 7). yTFIIA (1.5
mM) was also added to all reactions. In Figure 8B, reactions weretors [Thompson et al., 1993]). The suspension was centrifuged again
for 30 min at 5,000 rpm in an RC3B centrifuge (Sorvall). The superna- treated with holoenzyme, alone (lanes 2 and 4), in the presence of
4 mM ATP (lanes 3 and 5), or in the presence of 4 mM ATPgS (lanetant was mixed with 200 g (dry) of BioRex 70 and stirred for 20 min.
The suspension was packed into a column with a 5 cm diameter 6) for 30 min at 308C, followed by addition of 4 mM yTBP in the
presence of 1.5 mM yTFIIA.and washed with 1.5 liters of buffer A plus 100 mM KOAc. Bound
RNA Polymerase II Holoenzyme Contains SWI/SNF
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Recombinant yTBP was purified as described (Hoey et al., 1990), Litingtung, Y., Schaffner, W., and Corden, J.L. (1995). RNA polymer-
ase II C-terminal domain required for enhancer-driven transcription.except that the heparin peak was further purified on a Mono S HR5/
5 FPLC column (Pharmacia). Recombinant yTFIIA was purified as Nature 374, 660±662.
described (Ranish et al., 1992). Happel, A.M., Swanson, M.S., and Winston, F. (1991). The SNF2,
SNF5 and SNF6 genes are required for Ty transcription in Saccharo-
Supercoiling Reduction Assay myces cerevisiae. Genetics 128, 69±77.
Plasmid chromatin was assembled and purified as described (Kwon Hengartner, C.J.,Thompson, C.M., Zhang, J., Chao, D.M., Liao, S.M.,
et al., 1994). Reactions, total volume 12.5 ml, contained chromatin Koleske, A.M., Okamura, S., and Young, R.A. (1995). Association of
(2 ng of DNA), 1 U of topoisomerase I (Promega), 2.5 ml of 30% an activator with an RNA polymerase II holoenzyme. Genes Dev. 9,
glycerol gradient buffer, 7 ml of buffer A minus KCl, 7 mM MgCl2, 897±910.
50±100 mM KOAc (final), 4 mM ATP where indicated, and 2 ml of
Hirschhorn, J.N., Brown, S.A., Clark, C.D., and Winston, F. (1992).holoenzyme Mono S fractions or 1 ml of SRB/SWI/SNF complex
Evidence that SNF2/SWI2 and SNF5 activate transcription in yeastMono Q fractions. Reactions were stopped after 90 min at 308C by
by altering chromatin structure. Genes Dev. 6, 2288±2298.addition of 6 ml of stop buffer (3% SDS, 100 mM EDTA, 50 mM
Hoey, T., Dynlacht, B.D., Peterson, M.G., Pugh, B.F., and Tjian, R.Tris±HCl [pH 8.0], 25% glycerol, 2 mg/ml proteinase K). Reactions
(1990). Isolation and characterization of the Drosophila gene encod-were incubated for 90 min at 378C and resolved on a 2% agarose
ing the TATA box binding protein, TFIID. Cell 61, 1179±1186.gel (50 mM Tris±phosphate [pH 7.3], 1mM EDTA) for 40 hr, at 40 V.
Gels were dried and exposed to film. Imbalzano, A.N., Kwon, H., Green, M.R., and Kingston, R.E. (1994).
Facilitated binding of TATA-binding protein to nucleosomal DNA.
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